Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
157
datasets available to search
ShareScore release 0.7.1
Dataset results
157 results for “ustekinumab”
Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
ClinicalTrials.gov study NCT02826603. IPD Sharing: UNDECIDED. Countries: 11. Publications: 4.
Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab
ClinicalTrials.gov study NCT03553823. IPD Sharing: UNDECIDED. Countries: 3. Publications: 1.
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
ClinicalTrials.gov study NCT02074982. IPD Sharing: UNDECIDED. Countries: 24. Publications: 5.
A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
ClinicalTrials.gov study NCT03981744. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
ClinicalTrials.gov study NCT01369342. IPD Sharing: Not stated. Countries: 22. Publications: 12.
A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis
ClinicalTrials.gov study NCT02437162. IPD Sharing: Not stated. Countries: 7. Publications: 2.
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
ClinicalTrials.gov study NCT04882072. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
ClinicalTrials.gov study NCT02203032. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
ClinicalTrials.gov study NCT01713400. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
ClinicalTrials.gov study NCT02054481. IPD Sharing: Not stated. Countries: 7. Publications: 3.
Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
ClinicalTrials.gov study NCT02199496. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
ClinicalTrials.gov study NCT01389973. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
ClinicalTrials.gov study NCT02407223. IPD Sharing: Not stated. Countries: 14. Publications: 1.
A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT00267969. IPD Sharing: Not stated. Countries: 3. Publications: 2.
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03782376. IPD Sharing: YES. Countries: 12. Publications: 2.
Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
ClinicalTrials.gov study NCT01708629. IPD Sharing: YES. Countries: 11. Publications: 6.
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
ClinicalTrials.gov study NCT04533737. IPD Sharing: NO. Countries: 12. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
ClinicalTrials.gov study NCT02438787. IPD Sharing: Not stated. Countries: 19. Publications: 2.
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
ClinicalTrials.gov study NCT03107793. IPD Sharing: Not stated. Countries: 12. Publications: 4.
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00307437. IPD Sharing: Not stated. Countries: 7. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.